[{"address1": "1800 Sierra Point Parkway", "address2": "Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 484 0899", "website": "https://dayonebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.", "fullTimeEmployees": 181, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeremy  Bender M.B.A., Ph.D.", "age": 53, "title": "CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 1195600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles N. York II, M.B.A.", "age": 47, "title": "COO & CFO", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 854200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Dubow J.D.", "age": 57, "title": "General Counsel, Chief Compliance Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 692700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Stubenrauch Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jaa  Roberson", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Davy  Chiodin Ph.D., Pharm.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lauren  Merendino M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Elly  Barry M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.27, "open": 6.21, "dayLow": 6.15, "dayHigh": 6.315, "regularMarketPreviousClose": 6.27, "regularMarketOpen": 6.21, "regularMarketDayLow": 6.15, "regularMarketDayHigh": 6.315, "payoutRatio": 0.0, "beta": -1.241, "forwardPE": -5.598214, "volume": 966514, "regularMarketVolume": 966514, "averageVolume": 1410133, "averageVolume10days": 1531560, "averageDailyVolume10Day": 1531560, "bid": 4.48, "ask": 7.92, "bidSize": 1, "askSize": 2, "marketCap": 635539712, "fiftyTwoWeekLow": 6.08, "fiftyTwoWeekHigh": 16.76, "priceToSalesTrailing12Months": 3.9249744, "fiftyDayAverage": 7.3154, "twoHundredDayAverage": 11.667075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 165438672, "profitMargins": -0.42663, "floatShares": 71940998, "sharesOutstanding": 101362000, "sharesShort": 17702239, "sharesShortPriorMonth": 17481507, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.17469999, "heldPercentInsiders": 0.17028, "heldPercentInstitutions": 0.946, "shortRatio": 15.41, "shortPercentOfFloat": 0.2599, "impliedSharesOutstanding": 101362000, "bookValue": 4.731, "priceToBook": 1.3253012, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -69080000, "trailingEps": -0.65, "forwardEps": -1.12, "enterpriseToRevenue": 1.022, "enterpriseToEbitda": -0.874, "52WeekChange": -0.5393093, "SandP52WeekChange": 0.09362543, "quoteType": "EQUITY", "currentPrice": 6.27, "targetHighPrice": 36.0, "targetLowPrice": 20.0, "targetMeanPrice": 28.0, "targetMedianPrice": 27.0, "recommendationMean": 1.625, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 473020000, "totalCashPerShare": 4.667, "ebitda": -189212000, "totalDebt": 2916000, "quickRatio": 10.257, "currentRatio": 10.624, "totalRevenue": 161922000, "debtToEquity": 0.608, "revenuePerShare": 1.665, "returnOnAssets": -0.27812, "returnOnEquity": -0.17797, "grossProfits": 153759008, "freeCashflow": -155793248, "operatingCashflow": -87381000, "grossMargins": 0.94958997, "ebitdaMargins": -1.16854, "operatingMargins": -1.3350301, "financialCurrency": "USD", "symbol": "DAWN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.0, "shortName": "Day One Biopharmaceuticals, Inc", "longName": "Day One Biopharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622122200000, "postMarketChangePercent": 0.797451, "postMarketPrice": 6.32, "postMarketChange": 0.0500002, "regularMarketChange": 0.0, "regularMarketDayRange": "6.15 - 6.315", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1410133, "fiftyTwoWeekLowChange": 0.19000006, "fiftyTwoWeekLowChangePercent": 0.03125001, "fiftyTwoWeekRange": "6.08 - 16.76", "fiftyTwoWeekHighChange": -10.49, "fiftyTwoWeekHighChangePercent": -0.62589496, "fiftyTwoWeekChangePercent": -53.93093, "earningsTimestamp": 1746561660, "earningsTimestampStart": 1752004800, "earningsTimestampEnd": 1753300800, "earningsCallTimestampStart": 1746563400, "earningsCallTimestampEnd": 1746563400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.65, "epsForward": -1.12, "epsCurrentYear": -1.3602, "priceEpsCurrentYear": -4.6096163, "fiftyDayAverageChange": -1.0454001, "fiftyDayAverageChangePercent": -0.14290403, "twoHundredDayAverageChange": -5.397075, "twoHundredDayAverageChangePercent": -0.46259025, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-05-27", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1748044302, "regularMarketTime": 1748030400, "exchange": "NMS", "messageBoardId": "finmb_704589075", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketPrice": 6.27, "marketState": "CLOSED", "displayName": "Day One Biopharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-24"}]